Abstract
Living organ donors frequently incur non-medical expenses for travel, accommodation, prescription drugs, loss of income, and child care in conjunction with organ donation. Despite international precedent and widespread public support, Canada currently lacks a unified strategy to reimburse donors for these expenses. In 2005, we communicated with 78 individuals within the field of Canadian transplantation to identify which initiatives for reimbursement of living donors existed in each province. Saskatchewan was the only province in which public employees were granted paid leave for organ donation. Six provincial governments partially reimbursed travel and accommodation. At the federal level, other expenses could be partially reimbursed through an income tax credit, while the Employment Insurance program and the Canada Pension Plan provided funding for donors who become unemployed or develop longterm disability as a result of donation. Charities helped a limited number of patients in financial need through grants and no-interest loans, but funding was generally limited by contributions received. While reimbursing living donors for their non-medical expenses is considered just, existing programs only partially reimburse expenses and are not available in all provinces. Developing future reimbursement policies will remove a disincentive faced by some potential donors, and may increase rates of transplantation in Canada.
MeSH terms: Living donors, kidney transplantation, health policy, economics, costs and cost analysis
Résumé
Les donneurs vivants engagent souvent des dépenses extramédicales (frais de déplacement et d’hébergement, achat de médicaments sur ordonnance, perte de revenus, frais de garde d’enfants) en liaison avec leurs dons d’organes. Or, malgré les précédents internationaux et l’appui généralisé du public, le Canada n’a pas de stratégie unifiée pour leur rembourser ces dépenses. En 2005, nous avons communiqué avec 78 intervenants du secteur de la transplantation au Canada afin de repérer, dans chaque province, les initiatives de remboursement des dépenses des donneurs vivants. La Saskatchewan est la seule province qui octroie un congé payé aux fonctionnaires faisant un don d’organe. Six administrations provinciales remboursent en partie leurs frais de déplacement et d’hébergement. Dans l’administration fédérale, d’autres frais peuvent être partiellement remboursés par un crédit d’impôt sur le revenu, et le programme d’assurance-emploi et le Régime de pensions du Canada prévoient des fonds pour les donneurs qui ont perdu leur emploi ou qui présentent des limitations fonctionnelles de longue durée en raison d’un don d’organe. Des oeuvres de bienfaisance aident un petit nombre de patients en difficulté financière en leur octroyant des subventions et des prêts sans intérêt, mais le montant du financement est en général limité par les contributions reçues. On considère qu’il est juste de rembourser les dépenses extramédicales des donneurs vivants, mais les programmes existants n’en remboursent qu’une partie, et toutes les provinces n’offrent pas ces programmes. L’élaboration de politiques de remboursement abolirait un obstacle de plus pour les donneurs éventuels et pourrait accroître les taux de transplantation au Canada.
References
- 1.Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, Patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725–30. doi: 10.1056/NEJM199912023412303. [DOI] [PubMed] [Google Scholar]
- 2.Evans RW, Manninen DL, Garrison LP, Jr., Hart LG, Blagg CR, Gutman RA, et al. The quality of life of patients with end-stage renal disease. N Engl J Med. 1985;312:553–59. doi: 10.1056/NEJM198502283120905. [DOI] [PubMed] [Google Scholar]
- 3.Whiting JF, Kiberd B, Kalo Z, Keown P, Roels L, Kjerulf M. Cost-effectiveness of organ donation: Evaluating investment into donor action and other donor initiatives. Am J Transplant. 2004;4:569–73. doi: 10.1111/j.1600-6143.2004.00373.x. [DOI] [PubMed] [Google Scholar]
- 4.Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS. Health economic evaluations: The special case of end-stage renal disease treatment. Med Decis Making. 2002;22:417–30. doi: 10.1177/027298902320556118. [DOI] [PubMed] [Google Scholar]
- 5.Sagmeister M, Mullhaupt B, Kadry Z, Kullak-Ublick GA, Clavien PA, Renner EL. Costeffectiveness of cadaveric and living-donor liver transplantation. Transplantation. 2002;73:616–22. doi: 10.1097/00007890-200202270-00025. [DOI] [PubMed] [Google Scholar]
- 6.Canadian Organ Replacement Registry. 2007. Available online at: https://doi.org/www.cihi.ca (Accessed April 17, 2007).
- 7.Clarke KS, Klarenbach S, Vlaicu S, Yang RC, Garg AX. The direct and indirect economic costs incurred by living kidney donors-a systematic review. Nephrol Dial Transplant. 2006;21:1952–60. doi: 10.1093/ndt/gfl069. [DOI] [PubMed] [Google Scholar]
- 8.Clemens KK, Thiessen-Philbrook H, Parikh CR, Yang RC, Karley ML, Boudville N, et al. Psychosocial health of living kidney donors: A systematic review. Am J Transplant. 2006;6:2965–77. doi: 10.1111/j.1600-6143.2006.01567.x. [DOI] [PubMed] [Google Scholar]
- 9.Yang RC, Thiessen-Philbrook H, Klarenbach S, Vlaicu S, Garg AX. Insurability of living organ donors: A systematic review. Am J Transplant. 2007;76:1542–51. doi: 10.1111/j.1600-6143.2007.01793.x. [DOI] [PubMed] [Google Scholar]
- 10.Johnson EM, Anderson JK, Jacobs C, Suh G, Humar A, Suhr BD, et al. Long-term follow-up of living kidney donors: Quality of life after donation. Transplantation. 1999;67:717–21. doi: 10.1097/00007890-199903150-00013. [DOI] [PubMed] [Google Scholar]
- 11.Council of Europe. Additional Protocol to the Convention on Human Rights and Biomedicine Concerning Transplantation of Organs and Tissues of Human Origin. 2006. [Google Scholar]
- 12.World Medical Association. Statement on Human Organ and Tissue Donation and Transplantation Policy. 2005. [Google Scholar]
- 13.Hiller J, Sroka M, Weber R, Morrison AS, Ratner LE. Identifying donor concerns to increase live organ donation. J Transpl Coord. 1998;8:51–54. doi: 10.7182/prtr.1.8.1.m5h2r1217m353t16. [DOI] [PubMed] [Google Scholar]
- 14.Wolters HH, Heidenreich S, Senninger N. Living donor kidney transplantation: Chance for the recipient–financial risk for the donor? Transplant Proc. 2003;35:2091–92. doi: 10.1016/S0041-1345(03)00675-4. [DOI] [PubMed] [Google Scholar]
- 15.Gaston RS, Danovitch GM, Epstein RA, Kahn JP, Matas AJ, Schnitzler MA. Limiting financial disincentives in live organ donation: A rational solution to the kidney shortage. Am J Transplant. 2006;6:2548–55. doi: 10.1111/j.1600-6143.2006.01492.x. [DOI] [PubMed] [Google Scholar]
- 16.Klarenbach S, Vlaicu S, Garg AX. Reimbursing living organ donors for incurred costs. Am J Transplant. 2007;7(5):1308. doi: 10.1111/j.1600-6143.2006.01682.x. [DOI] [PubMed] [Google Scholar]
- 17.Klarenbach S, Garg AX, Vlaicu S. Living organ donors face financial barriers: A national reimbursement policy is needed. CMAJ. 2006;174:797–98. doi: 10.1503/cmaj.051168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Canadian Revenue Agency. Which medical expenses are eligible? 2007. [Google Scholar]
- 19.Service Canada: Employment Insurance. 2005. Available online at: https://doi.org/www.servicecanada.gc.ca (Accessed September 29, 2007).
- 20.Statistics Canada. Employment Insurance Coverage Survey. 2005. [Google Scholar]
- 21.Perspectives on Labor and Income. 2003.
- 22.Lavis JN, Robertson D, Woodside JM, McLeod CB, Abelson J. How can research organizations more effectively transfer research knowledge to decision makers? Milbank Q. 2003;81:221–22. doi: 10.1111/1468-0009.t01-1-00052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Canadian Council for DonationTransplantation. Enhancing living donation. 2007. [Google Scholar]